BNP Paribas unit holds 3.09M PROCEPT BioRobotics (PRCT) shares, 5.5%

Rhea-AI Filing Summary

BNP Paribas Asset Management Holding S.A. disclosed a significant ownership position in PROCEPT BioRobotics Corp common stock. As of 12/31/2025, it beneficially owned 3,094,649 shares, representing 5.5% of the outstanding common stock.

The firm reported sole voting power over 2,990,031 shares and sole dispositive power over 3,094,649 shares, with no shared voting or dispositive power. It certified that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of PROCEPT BioRobotics.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

PROCEPT BioRobotics Corp

(Name of Issuer)

Common Stock

(Title of Class of Securities)

74276L105

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 74276L105

1

Names of Reporting Persons

BNP Paribas Asset Management Holding S.A.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

FRANCE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,990,031.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,094,649.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,094,649.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.5 %

12

Type of Reporting Person (See Instructions)

HC

Comment for Type of Reporting Person: Shares reported are inclusive of the Parent Holding Company's subsidiaries/associated entities: BNPP Paribas Asset Management USA, Inc., BNP Paribas Asset Management Europe, and AXA Investment Managers UK Limited

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PROCEPT BioRobotics Corp
(b)	Address of issuer's principal executive offices: 150 BAYTECH DRIVE, SAN JOSE, CALIFORNIA, 95134.
Item 2.
(a)	Name of person filing: BNP Paribas Asset Management Holdings SA
(b)	Address or principal business office or, if none, residence: 8, Rue Du Port 92729 Nanterre
(c)	Citizenship: France
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 74276L105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
	A parent holding company.
Item 4.	Ownership
(a)	Amount beneficially owned: 3,094,649
(b)	Percent of class: 5.5 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2,990,031
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 3,094,649
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Shares reported are those beneficially owned by one IA and two FI entities associated with the asset management holding company, BNP Paribas Asset Management Holdings SA, as referenced in the Exhibit.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ? 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to HC is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BNP Paribas Asset Management Holding S.A.

Signature:	Sylvain Noyelle
Name/Title:	Head of Compliance
Date:	02/11/2026

FAQ

How many PROCEPT BioRobotics (PRCT) shares does BNP Paribas Asset Management beneficially own?

BNP Paribas Asset Management Holding S.A. beneficially owns 3,094,649 PROCEPT BioRobotics shares. The Schedule 13G states this position represents 5.5% of the common stock as of 12/31/2025, making it a significant institutional holder in PRCT.

What percentage of PROCEPT BioRobotics (PRCT) does BNP Paribas Asset Management report owning?

BNP Paribas Asset Management reports owning 5.5% of PROCEPT BioRobotics’ common stock. According to the Schedule 13G, this 5.5% stake corresponds to 3,094,649 beneficially owned shares of PRCT as of 12/31/2025.

How much voting power does BNP Paribas Asset Management have in PROCEPT BioRobotics (PRCT)?

BNP Paribas Asset Management has sole voting power over 2,990,031 PRCT shares. The filing shows no shared voting power, meaning all reported voting authority is held solely, covering most of its 3,094,649 beneficially owned shares.

Does BNP Paribas Asset Management share dispositive power over PROCEPT BioRobotics (PRCT) shares?

No, the firm reports only sole dispositive power over PRCT shares. The Schedule 13G lists 3,094,649 shares with sole dispositive power and zero shares with shared dispositive power, indicating exclusive decision-making over those holdings.

Is BNP Paribas Asset Management’s PROCEPT BioRobotics (PRCT) stake intended to influence control of the company?

The filing states the PRCT shares are held in the ordinary course of business, not to influence control. BNP Paribas Asset Management certifies the securities were not acquired and are not held for changing or influencing control of PROCEPT BioRobotics.

Which entities are included in BNP Paribas Asset Management’s reported PROCEPT BioRobotics (PRCT) holdings?

The 3,094,649 PRCT shares include holdings of several affiliated entities. The filing notes that shares are inclusive of BNP Paribas Asset Management USA, Inc., BNP Paribas Asset Management Europe, and AXA Investment Managers UK Limited associated with the parent holding company.